# THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.

> **NCT02381769** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 55 (actual)

## Conditions studied

- Alcoholic Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Soybean based lipid emulsion

## Key facts

- **NCT ID:** NCT02381769
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2016-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381769, "THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02381769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*